Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension
Completed
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 4
2009-12-01
This study is designed to compare the safety and efficacy of levamlodipine besylate (2.5mg or
5mg) versus amlodipine maleate (5mg) in patients with mild to moderate essential
hypertension.
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
Completed
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1
2018-05-31
This study are (1) to assess the relative bioavailability (BA) of a single oral dose of
either 5 mg of Levamlodipine Maleate Tablets from CSPC or 10 mg of Amlodipine Besylate Tablet
(NORVASC®) from Pfizer Inc. under fasting condition in male and female healthy subjects; and
(2) to evaluate food effect on the PK profile of Levamlodipine Maleate Tablets from CSPC.
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
Completed
Conjupro Biotherapeutics
Phase 1
2018-05-31
This study are (1) to assess the relative bioavailability (BA) of a single oral dose of
either 5 mg of Levamlodipine Maleate Tablets from CSPC or 10 mg of Amlodipine Besylate Tablet
(NORVASC®) from Pfizer Inc. under fasting condition in male and female healthy subjects; and
(2) to evaluate food effect on the PK profile of Levamlodipine Maleate Tablets from CSPC.
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy Subjects
Completed
Conjupro Biotherapeutics, Inc.
Phase 1
2018-05-31
This study are (1) to assess the relative bioavailability (BA) of a single oral dose of
either 5 mg of Levamlodipine Maleate Tablets from CSPC or 10 mg of Amlodipine Besylate Tablet
(NORVASC®) from Pfizer Inc. under fasting condition in male and female healthy subjects; and
(2) to evaluate food effect on the PK profile of Levamlodipine Maleate Tablets from CSPC.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
